BBIT-Therapeutics, LDA
My visitor profile
BBIT-Therapeutics, LDA
Description of your activity
-
BEAT Therapeutics is a pre-clinical stage biotech company working on the development of first-in-class therapies against hard-to-treat cancers.
We leverage the DNA Damage Response (DDR) to unlock new therapeutic opportunities for cancer patients.
Our lead drug candidate, under preclinical development, is a new-class small molecule that inhibits cancer cells DNA repair via disruption of a central pathway in homologous recombination (HR).
More information
- We work with a steadfast commitment to patient well-being and strive to set new benchmarks in treatment efficacy, minimize side effects, and advance the frontiers of healthcare innovation.
Participation objectives
Partnering objectives
- Network development, Other
Description of my participation objective
- As an MSc student conducting an internship at a biotech startup (BEAT Therapeutics), attending the partnering conference presents a valuable chance to explore industry dynamics firsthand and expand my professional network. Engaging with experts and peers will provide insights into current trends and potential career paths within the field. I see this opportunity as essential for both learning and networking to advance my career aspirations in the pharmaceutical sector.